CANCER FUND

CANCER FUND is seeking AI & Computational Biology Experts to help evaluate AI-driven precision medicine and computational biology innovations that we may support with our future investments. What You’ll Do: Assess emerging technologies in AI-driven biomarker discovery and computational biology Provide technical diligence on breakthrough innovations in oncology and precision medicine Support investment decisions by evaluating scientific and commercial viability Work alongside our investment and diligence team to identify high-potential startups Who You Are: A subject matter expert in AI-driven drug discovery, computational biology, or bioinformatics Experienced in machine learning applications for biomarker identification and patient stratification Passionate about oncology innovations and venture-backed biotech Comfortable analyzing multi-omics data, predictive models, and clinical-stage AI applications As a CANCER FUND AI & Computational Biology Expert, you may periodically contribute a few hours to help support our investment decisions. While this is an unpaid role, our experts are welcome to add their work helping us advance cancer innovations to their list of professional accomplishments. Who We Are: CANCER FUND is a venture firm investing in early-stage companies developing and commercializing innovations with the potential to transform cancer care. Our experts play a critical role in evaluating companies developing AI-driven precision medicine platforms, computational biology innovations, and digital health technologies that could improve patient outcomes, expand access to care, and reduce the cost of care. How to Learn More: If you have relevant expertise and are interested in joining the team, learn more and apply here: www.cancerfund.com/team Know someone who might be a great fit? Feel free to share this opportunity. #AIinHealthcare #ComputationalBiology #VentureCapital #CancerInnovation #Oncology #PrecisionMedicine #CancerFund #ImpactInvesting

CANCER FUND is seeking Synthetic Biology & Gene Therapy Delivery Experts to help evaluate cell and gene therapy innovations that we may support with our future investments. ?What You’ll Do: ? Assess emerging technologies in synthetic biology and gene therapy delivery ? Provide technical diligence on breakthrough innovations in oncology ? Support investment decisions by helping evaluate scientific and commercial viability ? Work alongside our investment and diligence team to identify high-potential startups Who You Are: ? A subject matter expert in synthetic biology, gene editing, or gene therapy ? Experienced with AAV, lentiviral, or non-viral gene delivery platforms ? Passionate about oncology innovations and venture-backed biotech ? Comfortable analyzing preclinical and early-stage clinical data ?As a CANCER FUND Synthetic Biology & Gene Therapy Delivery Expert, you may periodically contribute a few hours to help support our investment decisions. While this is an unpaid role, our experts are welcome to add their work helping us advance cancer innovations to their list of professional accomplishments. Who We Are: CANCER FUND is a venture firm investing in early-stage companies developing and commercializing innovations with the potential to transform cancer. Our experts play a critical role in evaluating companies developing cell and gene therapies that could improve patient outcomes, expand access to care, and reduce the cost of care. How to Learn More:? If you have relevant expertise and are interested in joining the team, learn more and apply here: www.cancerfund.com/team Know someone who might be a great fit? Feel free to share this opportunity. #GeneTherapy #SyntheticBiology #VentureCapital #CancerInnovation #Oncology #CellTherapy? #CancerFund #ImpactInvesting

CANCER FUND is assembling a Cell & Gene Therapy Team to help evaluate innovations we may support with our future investments. As a CANCER FUND Cell & Gene Therapy Expert, you may contribute a few hours per week over 2-3 weeks as we make our investment decisions. While this is an unpaid role, our experts are welcome to add their work helping us advance cancer innovations to their list of professional accomplishments. We are currently seeking the following Experts: ? Synthetic Biology & Gene Therapy Delivery (AAV vector engineering, transcriptional regulation, immunogenicity) ? Bioprocessing & GMP Manufacturing (scale-up, viral vector production, regulatory compliance) ? Regulatory Strategy & Clinical Development (FDA pathways, first-in-human trial design, biomarkers) ? Biotech Investment & Business strategy (commercial viability, competitive analysis, reimbursement) How You Can Contribute: ? Assess the scientific, technical, and commercial viability of multiple cell and gene therapy innovations ? Work alongside industry leaders to evaluate novel approaches to treating hepatocellular carcinoma and other cancers ? Provide expert insights to help shape our investment decisions ? Our Experts may have the opportunity to invest with CANCER FUND but are not required to do so Who We Are: CANCER FUND is a venture firm investing in early-stage companies developing and commercializing innovations with the potential to transform cancer. This team will play a critical role in evaluating companies developing cell and gene therapies that could improve patient outcomes, expand access to care, and reduce the cost of care. How to Learn More:? If you have relevant expertise and are interested in joining the team, learn more and apply here: www.cancerfund.com/team Know someone who might be a great fit? Feel free to share this opportunity.

Cancer Awareness Day is more than a day of recognition—it’s a call to action. At CANCER FUND, we go beyond acknowledging the fight against cancer—we invest in the future of it. Our focus is not on awareness, but on? what comes next, providing a way for our community to support. ?- The next breakthrough. - The next technology. - The next investment that could change lives. We believe that innovation—not just awareness—will change the survival curve. We help capitalize bold founders developing transformational cancer innovations because while awareness is important, alone it isn’t enough.?? If you’re ready to move beyond awareness and research and into impact, let’s talk. #CancerAwarenessDay #CancerFund #InvestInInnovation

Cancer Awareness Day is more than a day of recognition—it’s a call to action. At CANCER FUND, we go beyond acknowledging the fight against cancer—we invest in the future of it. Our focus is not on awareness, but on? what comes next, providing a way for our community to support. ?- The next breakthrough. - The next technology. - The next investment that could change lives. We believe that innovation—not just awareness—will change the survival curve. We help capitalize bold founders developing transformational cancer innovations because while awareness is important, alone it isn’t enough.?? If you’re ready to move beyond awareness and research and into impact, let’s talk. #CancerAwarenessDay #CancerFund #InvestInInnovation

Cancer Awareness Day is more than a day of recognition—it’s a call to action. At CANCER FUND, we go beyond acknowledging the fight against cancer—we invest in the future of it. Our focus is not on awareness, but on? what comes next, providing a way for our community to support. ?- The next breakthrough. - The next technology. - The next investment that could change lives. We believe that innovation—not just awareness—will change the survival curve. We help capitalize bold founders developing transformational cancer innovations because while awareness is important, alone it isn’t enough.?? If you’re ready to move beyond awareness and research and into impact, let’s talk. #CancerAwarenessDay #CancerFund #InvestInInnovation

CANCER FUND Impact Investments? is expanding our Venture Partner team to help grow our portfolio in 2025. CANCER FUND is a venture capital firm investing in cancer innovation. Our Venture Partners play a critical role in identifying, evaluating, and supporting transformative early-stage companies focused on therapies, diagnostics, and technologies that can make a real difference in patient outcomes. ?Why Join Us? ? Be part of a mission-driven team making a real impact. ? Engage directly with groundbreaking cancer innovations. ? Collaborate with other investors, entrepreneurs, and industry leaders. ? Help drive investment decision-making and portfolio growth. Who Are We Looking For? We’re seeking PARTNERS (not employees) who are passionate about bringing their expertise in life sciences, medical technologies, healthcare, or early-stage investing and are willing to contribute their talents, time, and capital to help support cancer innovation. To apply or to learn more, visit https://lnkd.in/gc7ex4NA

CANCER FUND is pleased to announce its investment in NXgenPort, an early-stage company developing technology to advance remote monitoring of cancer patients’ health. This marks Cancer Fund I’s seventh investment and reflects its dedication to fostering impactful innovations in oncology. NXgenPort is designing an implantable smart port that integrates conventional vascular access with technology intended to provide daily, in vivo monitoring of key patient metrics, such as changes in blood cell counts, body temperature and pulse. By utilizing light-scattering technology, NXgenPort’s solution seeks to enable regular data collection that can be synced to a cloud-based dashboard for physician access. This system aims to address gaps in care by supporting earlier detection of potential complications, such as infections, and helping avoid delays in treatment, thus improving outcomes and reducing costs. “We are excited to partner with NXgenPort as they work to bring this promising innovation to life,” said Anthony Bajoras, Managing Director of CANCER FUND. “The potential for this technology to improve patient outcomes while reducing healthcare costs aligns strongly with our mission to invest in transformative cancer care.” “Cancer Fund’s investment and collaborative approach bring valuable expertise as we continue to develop our smart port technology,” said Cathy Skinner, CEO of NXgenPort. “We look forward to working with their team to advance this innovation and improve the standard of care for cancer patients.” Learn more about our investment in NXgenPort at https://lnkd.in/gngs2yVe. Ready to join the fight against cancer? Invest in Cancer Fund I—where passion, innovation, and impact come together to change lives. Submit your indication of interest now at www.cancerfund.com/invest!

?? At CANCER FUND, we’re changing the future of Cancer Care. ?? We believe in the power of innovation to transform lives, and that’s why we invest in cutting-edge solutions aimed at tackling the toughest challenges in cancer treatment. By empowering startups and innovators, we're helping accelerate breakthroughs that will ease the burden on patients, families, and communities affected by this devastating disease. ?? ?? Our mission is clear: make an impact on Cancer through strategic investment in the brightest minds and boldest innovations. Whether it's early detection, targeted therapies, or patient care solutions, we're here to back the innovators who are leading the charge. ?? Ready to join the fight against cancer? Learn more about our portfolio and how we're driving both impact and returns for our investors, while fostering life-saving advancements. Together, we can help cancer innovations reach patients faster. ?? Visit cancerfund.com. Learn how you can invest in the future of cancer care. Let’s make a difference. #CancerInnovation #InvestInChange #ImpactInvesting #CancerResearch #HealthTech

As an expert in the field of Cancer diagnosis and treatment, you can play a key role in supporting the development of innovative solutions that can improve patient outcomes and save lives. By sharing your knowledge and expertise with these ventures, you can help them to identify new approaches and technologies that can accelerate the diagnosis process, improve the accuracy of test results, and streamline treatment plans. Some potential ways you can make an impact include: - Advising on the latest trends and advancements in Cancer diagnosis and treatment, including new technologies, therapies, and clinical trials. - Providing guidance on regulatory requirements and best practices for developing medical devices, diagnostic tests, and other healthcare products. - Collaborating with the ventures to identify and prioritize key challenges and opportunities in the Cancer care landscape. - Offering feedback and insights on product prototypes, user testing, and other aspects of the development process. - Connecting the ventures with other experts, stakeholders, and potential partners in the Cancer care community. By leveraging your expertise and experience, you can help these ventures to overcome obstacles and achieve their goals, ultimately contributing to the fight against Cancer.